Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systems
- 1 January 1993
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 11 (12), 1179-1184
- https://doi.org/10.1016/0264-410x(93)90039-z
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cholera Toxin Enhances Alloantigen Presentation by Cultured Intestinal Epithelial CellsScandinavian Journal of Immunology, 1993
- Induction of Mucosal and Systemic Immunity to a Recombinant Simian Immunodeficiency Viral ProteinScience, 1992
- Proliferation and differentiation of human CD5+ and CD5− B cell subsets activated through their antigen receptors or CD40 antigensEuropean Journal of Immunology, 1992
- The adjuvant effect of Vibrio cholerae and Escherichia coli heat‐labile enterotoxins is linked to their ADP‐ribosyltransferase activityEuropean Journal of Immunology, 1992
- The mucosal immune system: from fundamental concepts to vaccine developmentVaccine, 1992
- Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation.The Journal of Experimental Medicine, 1990
- Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: Disproportionate cholera toxin enhancement of the IgA B cell responseEuropean Journal of Immunology, 1990
- Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigensVaccine, 1988
- Actions of cholera toxin and the prevention and treatment of choleraNature, 1981
- Cellular kinetics of the intestinal immune response to cholera toxoid in rats.The Journal of Experimental Medicine, 1975